Insider Transactions Reported by 10 Insiders of Cadrenal Therapeutics, Inc.

Symbol
CVKD on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ponte Vedra, FL

Insiders trading volume in the past year

Cadrenal Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Quang X. Pham CEO and Chairman, Director, 10%+ Owner $5.58M -$312K -5.3% Oct 24, 2025
Matthew Szot Chief Financial Officer $139K -$328K -70.3% Oct 24, 2025
Lee Scott Golden Director $21K Dec 2, 2025
Glynn Wilson Director Jan 23, 2025
Jeffrey Scott Cole Chief Operating Officer Jan 23, 2025
Douglas W. Losordo Chief Medical Officer Jan 18, 2024
John R. Murphy Director Jan 23, 2025
Steven Zelenkofske Director Jan 23, 2025
James J. Ferguson III Chief Medical Officer Feb 5, 2025
Robert Lisicki Director Jan 23, 2025

Recent Insider Transactions by Companies or Individuals for Cadrenal Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.